Telik, Inc. - 2004 Press Releases

2007 Press Releases
Go to:Events 2005 Press Releases 2006 Press Releases

December 8, 2007	Telik Reports Positive Results from Phase 1 Dose-Escalation Study of Telintra Tablets in Myelodysplastic Syndrome
December 3, 2007	Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
November 7, 2007	Telik Announces Financial Results for 2007 Third Quarter
November 1, 2007	Telik Announces 2007 Third Quarter Financial Release Conference Call and Webcast
October 25, 2007	Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of AURORA KINASE and VEGFR2
October 18, 2007	Telik Announces Presentation of Preclinical Data on Dual Inhibitors of AURORA KINASES and VEGFR2
October 15, 2007	FDA Removes Partial Hold on TELCYTA Clinical Development
September 19, 2007	Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference
September 4, 2007	Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
August 8, 2007	Telik Announces Financial Results for 2007 Second Quarter
August 1, 2007	Telik Announces 2007 Second Quarter Financial Release, Conference Call and Webcast
June 15, 2007	FDA Converts TELCYTA Full Clinical Hold to Partial Hold
June 4, 2007	Telik Announces Clinical Hold on TELCYTA^® Trials
June 3, 2007	Telik Reports Results of TELCYTA^® ASSIST-3 Trial
June 3, 2007	Telik Announces Top-Line Results of TELCYTA^® ASSIST-2 Trial
June 3, 2007	Telik Reports Results of TELCYTA^® ASSIST-1 Trial
May 3, 2007	Telik Announces First Quarter 2007 Financial Results
April 26, 2007	Telik Announces 2007 First Quarter Financial Release Conference Call and Webcast
April 17, 2007	Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of TELCYTA as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer
April 9, 2007	Telik Announces TELCYTA Clinical and Preclinical Presentations at AACR Meeting
February 22, 2007	Telik Announces Fourth Quarter and 2006 Year End Financial Results and 2007 Guidance
February 13, 2007	Telik Announces Corporate Restructuring
February 9, 2007	Telik Announces Year-End Financial Release, Conference Call and Webcast
February 8, 2007	SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate
January 3, 2007	Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference
	Top